These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 33837453)
1. Frontiers of therapy for hepatocellular carcinoma. Heller M; Parikh ND; Fidelman N; Owen D Abdom Radiol (NY); 2021 Aug; 46(8):3648-3659. PubMed ID: 33837453 [TBL] [Abstract][Full Text] [Related]
2. Emerging Trends in the Treatment of Advanced Hepatocellular Carcinoma: A Radiological Perspective. Kim GH; Kim JH; Kim PH; Chu HH; Gwon DI; Ko HK Korean J Radiol; 2021 Nov; 22(11):1822-1833. PubMed ID: 34431250 [TBL] [Abstract][Full Text] [Related]
3. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA Trials; 2012 Aug; 13():144. PubMed ID: 22913492 [TBL] [Abstract][Full Text] [Related]
4. Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation. Mu L; Chapiro J; Stringam J; Geschwind JF Cancer J; 2016; 22(6):365-372. PubMed ID: 27870678 [TBL] [Abstract][Full Text] [Related]
5. Bifocal hepatocellular carcinoma: Magnetic resonance imaging features after transarterial embolization. Picchia S; Bali MA Curr Probl Cancer; 2018; 42(3):319-321. PubMed ID: 29729826 [TBL] [Abstract][Full Text] [Related]
7. MRI features of treated hepatocellular carcinoma following locoregional therapy: a pictorial review. Alnammi M; Wortman J; Therrien J; Afnan J Abdom Radiol (NY); 2022 Jul; 47(7):2299-2313. PubMed ID: 35524803 [TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma with Intra-atrial Tumor Extension: Imaging Response and Oncologic Outcomes. Kolarich A; Frangakis C; Yarchoan M; Hong K; Georgiades C J Vasc Interv Radiol; 2021 Aug; 32(8):1203-1208.e1. PubMed ID: 34332718 [TBL] [Abstract][Full Text] [Related]
9. Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma. Saake M; Seuss H; Hammon M; Ellmann S; May M; Uder M; Schmid A Acta Radiol; 2020 Feb; 61(2):148-155. PubMed ID: 31189328 [No Abstract] [Full Text] [Related]
10. 2022 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for Transarterial Therapy of Hepatocellular Carcinoma: What's New? Lee IJ; Chun HJ; Chung JW Korean J Radiol; 2023 Jan; 24(1):6-9. PubMed ID: 36606613 [No Abstract] [Full Text] [Related]
11. In Vivo Proof of Superselective Transarterial Chemoembolization with 40-μm Drug-Eluting Beads in a Patient with Hepatocellular Carcinoma. She HL; Burgmans MC; Coenraadm M; Saraqueta AF Cardiovasc Intervent Radiol; 2016 Jan; 39(1):137-40. PubMed ID: 26085369 [No Abstract] [Full Text] [Related]
12. Liver-directed therapy for hepatocellular carcinoma. Narsinh KH; Duncan DP; Newton IG; Minocha J; Rose SC Abdom Radiol (NY); 2018 Jan; 43(1):203-217. PubMed ID: 29230556 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the response to locoregional and systemic treatment for hepatocellular carcinoma. Darnell A; Belmonte E; Reig M; Brú C Radiologia (Engl Ed); 2018; 60(5):424-436. PubMed ID: 30196841 [TBL] [Abstract][Full Text] [Related]